Preoperative statin intake and morbid events after isolated coronary artery bypass grafting

Journal of Clinical Anesthesia

Volumn 20, Issue 1, 2008, Pages 4-11

  Subramaniam, Kathirvel ^a   Koch, Colleen Gorman ^b   Bashour, Allen ^b   O'Connor, Michael ^b   Xu, Meng ^b   Gillinov, A Marc ^b   Starr, Norman J ^b  

^a PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Complication, mortality; Drugs, statins; Procedure, coronary artery bypass grafting; Risk, perioperative

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; STEROID;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG EFFECT; DRUG UTILIZATION; FEMALE; HEART ATRIUM FIBRILLATION; HEART DISEASE; HOSPITALIZATION; HUMAN; INTRAOPERATIVE PERIOD; KIDNEY DISEASE; LENGTH OF STAY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINITIS; MORBIDITY; NEUROLOGIC DISEASE; OBSERVATIONAL STUDY; PREMEDICATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROBABILITY; PROSPECTIVE STUDY; RESPIRATORY TRACT DISEASE; RISK REDUCTION; SCORING SYSTEM; SEPSIS; SEPTIC SHOCK; STATISTICAL SIGNIFICANCE; SURGICAL MORTALITY; TREATMENT OUTCOME;

COHORT STUDIES; CORONARY ARTERY BYPASS; CORONARY DISEASE; FEMALE; HOSPITAL MORTALITY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LENGTH OF STAY; LINEAR MODELS; MALE; MIDDLE AGED; PERIOPERATIVE CARE; RESEARCH DESIGN; RISK FACTORS; TREATMENT OUTCOME;

EID: 40749128473     PISSN: 09528180     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinane.2007.09.003     Document Type: Article

References (29)

1. Waldman A., and Kritharides L. The pleiotropic effects of HMG-CoA reductase inhibitors: their role in osteoporosis and dementia. Drugs 63 (2003) 139-152
2. Werner N., Nickenig G., and Laufs U. Pleiotropic effects of HMG-CoA reductase inhibitors. Basic Res Cardiol 97 (2002) 105-116
3. Futterman L.G., and Lemberg L. Statin pleiotropy: fact or fiction?. Am J Crit Care 13 (2004) 244-249
4. McFarlane S.I., Muniyappa R., Francisco R., and Sowers J.R. Clinical review 145: pleiotropic effects of statins: lipid reduction and beyond. J Clin Endocrinol Metab 87 (2002) 1451-1458
5. Collins R., Armitage J., Parish S., et al. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20,536 people with cerebrovascular disease or other high-risk conditions. Lancet 363 (2004) 757-767
6. Kertai M.D., Boersma E., Westerhout C.M., et al. Association between long-term statin use and mortality after successful abdominal aortic aneurysm surgery. Am J Med 116 (2004) 96-103
7. Lindenauer P.K., Pekow P., Wang K., et al. Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery. JAMA 291 (2004) 2092-2099
8. Poldermans D., Bax J.J., Kertai M.D., et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation 107 (2003) 1848-1851
9. Flaker G.C., Warnica J.W., Sacks F.M., et al. Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations. Cholesterol and Recurrent Events CARE Investigators. J Am Coll Cardiol 34 (1999) 106-112
10. Dotani M.I., Elnicki D.M., Jain A.C., and Gibson C.M. Effect of preoperative statin therapy and cardiac outcomes after coronary artery bypass grafting. Am J Cardiol 86 (2000) 1128-1130
11. Pan W., Pintar T., Anton J., et al. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation 110 Suppl I (2004) II41-II49
12. Rosenbaum P., and Rubin D. The central role of the propensity score in observational studies for causal effects. Biometrika 70 (1983) 41-55
13. Parsons L. Reducing bias in a propensity score matched-pair sample using greedy matching techniques. Proceedings of the 26th Annual SAS Users Group International Conference (2001), SAS Institute, Cary (NC) 214-226
14. Ali I.S., and Buth K.J. Preoperative statin use and outcomes following cardiac surgery. Int J Cardiol 103 (2005) 12-18
15. Clark L.L., Ikonomidis J.S., Crawford Jr. F.A., et al. Preoperative statin treatment is not associated with reduced postoperative mortality and morbidity in patients undergoing cardiac surgery: an 8-year retrospective cohort study. J Thoracic Cardiovasc Surg 131 (2006) 679-685
16. Collard C.D., Body S.C., Shernan S.K., et al. Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery. J Thoracic Cardiovasc Surg 132 (2006) 392-400
17. Argalious M., Motta P., Khandwala F., et al. "Renal dose" dopamine is associated with the risk of new-onset atrial fibrillation after cardiac surgery. Crit Care Med 33 (2005) 1327-1332
18. Subramaniam K., Koch C.G., Bashour A., et al. Statin therapy is associated with reduced incidence of atrial fibrillation after coronary artery bypass surgery. Anesth Analg 100 Suppl 4 (2005) A10
19. Young-Xu Y., Jabbour S., Goldberg R., et al. Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease. Am J Cardiol 92 (2003) 1379-1383
20. Siu C.W., Lau C.P., and Tse H.F. Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion. Am J Cardiol 92 (2003) 1343-1345
21. Koch C.G., Li L., Van Wagoner D., Duncan A., Gillinov A.M., and Blackstone E.H. Red cell transfusion is associated with an increased risk for postoperative atrial fibrillation. Ann Thorac Surg 82 (2006) 1747-1757
22. Shishehbor M.H., Brennan M.L., Aviles R.J., et al. Statins promote potent systemic antioxidant effects through specific inflammatory pathways. Circulation 108 (2003) 426-431
23. Birnbaum Y., Ashitkov T., Uretsky B.F., Ballinger S., and Motamedi M. Reduction of infarct size by short-term pretreatment with atorvastatin. Cardiovasc Drugs Ther 17 (2003) 25-30
24. Mensah K., Mocanu M.M., and Yellon D.M. Failure to protect the myocardium against ischemia/reperfusion injury after chronic atorvastatin treatment is recaptured by acute atorvastatin treatment: a potential role for phosphatase and tensin homolog deleted on chromosome ten?. J Am Coll Cardiol 45 (2005) 1287-1291
25. Christenson J.T. Preoperative lipid-control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. Eur J Cardiothorac Surg 15 (1999) 394-400
26. Heeschen C., Hamm C.W., Laufs U., et al. Withdrawal of statins increases event rates in patients with acute coronary syndromes. Circulation 105 (2002) 1446-1452
27. Hindler K., Shaw A.D., Samuels J., et al. Improved postoperative outcomes associated with preoperative statin therapy. Anesthesiology 105 (2006) 1079-1080
28. Atar S., Ye Y., Lin Y., et al. Atrovastatin induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cyclooxygenase-2. Am J Physiol Herat Circ Physiol 290 (2006) H1960-H1968
29. + channels. Coron Artery Dis 15 (2004) 53-58